Sarcopenia Treatment Market Expected to Hit USD 4.70 Billion by 2030, Claims AMR

According to the report published by Allied Market Research, the global sarcopenia treatment market generated $2.57 billion in 2020, and is anticipated to reach $4.70 billion by 2030, witnessing a CAGR of 6.1% from 2021 to 2030. In-depth information about opportunities, key drivers, restraints, and their impact analysis on the market is offered in the report.

Factors such as rise in the geriatric population and surge in initiatives taken by the government and private organizations propel the global sarcopenia treatment market. On the other hand, lack of effective therapies for sarcopenia in the market is expected to hinder the growth. Contrarily, rise in the adoption of supplements and increase in malnutrition and vitamin deficiency in developing countries are the factors that are expected to offer profitable market opportunities.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/10891

𝑰𝒎𝒑𝒂𝒄𝒕 𝒐𝒇 𝑪𝒐𝒗𝒊𝒅-19 𝒐𝒏 𝑺𝒂𝒓𝒄𝒐𝒑𝒆𝒏𝒊𝒂 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝑴𝒂𝒓𝒌𝒆𝒕-

The COVID-19 pandemic is anticipated to positively impact the sarcopenia treatment market.
As sarcopenia patients are more exposed to Covid-19 infection, the pandemic has caused a many sarcopenia cases, especially in the elder population.
Lockdown and uncertain food delivery chain led to unavailability of protein-rich and other nutritional food items. This affected the overall health of people and led to muscle loss and other muscle disorders in people suffering from other health conditions.

𝑮𝒆𝒕 𝒅𝒆𝒕𝒂𝒊𝒍𝒆𝒅 𝑪𝑶𝑽𝑰𝑫-19 𝒊𝒎𝒑𝒂𝒄𝒕 𝒂𝒏𝒂𝒍𝒚𝒔𝒊𝒔 𝒐𝒏 𝒕𝒉𝒆 𝑺𝒂𝒓𝒄𝒐𝒑𝒆𝒏𝒊𝒂 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 𝑴𝒂𝒓𝒌𝒆𝒕- https://www.alliedmarketresearch.com/request-for-customization/10891

The report offers detailed segmentation of the global sarcopenia treatment market based on the route of administration, treatment, distribution channel, and region.

Based on treatment, the protein supplement segment is accounted for the largest market share in 2020, contributing to more than two-fifths of the total share. On the other hand, the vitamin D and calcium supplement segment is estimated to witness the fastest CAGR of 7.4% from 2021 to 2030.

Based on the distribution channel, the hospital pharmacies segment contributed to the largest share in 2020, accounting for more than half of the global sarcopenia treatment market, and is projected to dominate the market during the forecast period. However, the online pharmacies segment is expected to manifest the highest CAGR of 8.8% from 2021 to 2030.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/10891

Based on region, Asia-Pacific contributed to the highest share in 2020, followed by North America and Europe, holding nearly two-fifths of the total market share, and is expected to maintain the lead throughout the forecast period. The region is expected to manifest the fastest CAGR of 7.5% during the forecast period.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Abbott laboratories, Inc.
American Way (Amway) Corporation
Bayer AG
GlaxoSmithKline plc.
Nestle S.A.
Pfizer, Inc.
Novartis AG
Sanofi, Inc.
Zydus Cadila, Ltd
F-Hoffmann La-Roche

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞-https://www.alliedmarketresearch.com/sarcopenia-treatment-market-A10526

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲-
𝐂𝐨𝐫𝐧𝐞𝐚𝐥 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/corneal-implants-market-A11924

𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐃𝐢𝐬𝐩𝐨𝐬𝐚𝐛𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/respiratory-disposables-market-A11235

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.